Chlorityle H Eye Drop contains Chloramphenicol 0.5% w/v + Hydroxypropylmethylcellulose 0.25% w/v, a dual-benefit ophthalmic formulation designed to treat bacterial eye infections while maintaining ocular surface lubrication. This combination supports faster recovery with improved patient comfort.
The antibiotic component Chloramphenicol works by inhibiting bacterial protein synthesis, effectively managing a wide range of gram-positive and gram-negative ocular pathogens, while HPMC enhances tear film stability, reducing dryness and irritation.
From a commercial perspective, Chlorityle H Eye Drop is a frequently prescribed ophthalmic antibiotic, suitable for clinics, hospitals, and general ophthalmic practice, ensuring consistent demand and repeat sales for franchise partners.
Including Chlorityle H Eye Drop in your portfolio strengthens the anti-infective ophthalmic segment, offering reliable turnover, strong prescriber acceptance, and portfolio depth for PCD pharma franchise businesses.